🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 21 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/03/2019 87,29 87,49 84,68 84,83 -3,18% 3,22% 685.100
19/03/2019 85,03 87,71 84,95 87,62 +3,31% 3,25% 1.167.100
18/03/2019 84,29 86,16 83,92 84,81 +0,50% 2,66% 557.300
15/03/2019 83,37 84,78 82,95 84,39 +1,71% 2,20% 740.400
14/03/2019 84,30 85,12 82,77 82,97 -1,14% 2,79% 444.800
13/03/2019 81,48 84,08 81,48 83,93 +3,66% 3,19% 897.400
12/03/2019 80,51 81,90 79,37 80,97 +1,19% 3,14% 752.100
11/03/2019 77,08 80,50 76,83 80,02 +4,11% 4,76% 864.700
08/03/2019 76,47 77,50 76,10 76,86 -0,26% 1,83% 659.800
07/03/2019 75,46 77,69 74,89 77,06 +2,03% 3,71% 742.300
06/03/2019 76,86 77,08 74,70 75,53 -1,47% 3,10% 947.700
05/03/2019 78,91 79,69 76,57 76,66 -2,84% 3,95% 857.100
04/03/2019 79,54 80,32 77,72 78,90 -0,29% 3,27% 596.500
01/03/2019 78,03 79,32 77,51 79,13 +2,43% 2,32% 1.212.200
28/02/2019 80,04 81,14 77,24 77,25 -4,23% 4,87% 880.500
27/02/2019 79,88 81,46 79,88 80,66 +0,55% 1,98% 1.035.400
26/02/2019 80,57 81,31 79,50 80,22 -0,90% 2,25% 808.900
25/02/2019 79,49 81,57 79,13 80,95 +2,59% 3,07% 776.800
22/02/2019 77,17 79,50 76,27 78,91 +2,07% 4,19% 994.200
21/02/2019 79,37 80,25 77,15 77,31 -2,58% 3,91% 845.200
20/02/2019 81,24 82,16 79,17 79,36 -1,89% 3,68% 905.100
19/02/2019 84,32 85,05 80,74 80,89 -4,07% 5,11% 967.100
15/02/2019 84,42 85,27 83,45 84,32 -0,27% 2,16% 644.100
14/02/2019 83,83 84,84 83,57 84,55 +0,71% 1,51% 764.900
13/02/2019 85,32 85,82 83,86 83,95 -0,73% 2,30% 731.600
12/02/2019 85,01 85,81 84,10 84,57 -0,09% 2,01% 880.000
11/02/2019 84,81 85,42 83,86 84,65 +0,31% 1,84% 1.123.800
08/02/2019 80,43 84,56 80,10 84,39 +4,12% 5,55% 1.364.800
07/02/2019 83,58 85,26 81,04 81,05 -3,97% 5,05% 1.175.400
06/02/2019 87,77 87,77 80,20 84,40 -3,85% 8,62% 2.347.300